Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Breakthrough CRISPR Technology Study Published in Nature
A groundbreaking research study by a team that included scientists from Benson Hill has been published […]
Theragent Secures Novel Stem Cell Bank Production Contract with Accelerated Biosciences
Theragent, a cell therapy Contract Development and Manufacturing Organization (CDMO) focused on advancing next-generation cancer […]
Autolomous to Provide Digital Solutions to Center for Breakthrough Medicines to Streamline and Automate Manufacturing of Cell & Gene Therapies
Autolomous LTD, the market-leading developer of critical manufacturing management systems for Cell and Gene Therapies (CGT), has announced […]
Neutron Therapeutics Announces Successful Generation of a Neutron Beam for BNCT at Shonan Kamakura General Hospital in Japan
Neutron Therapeutics (NT), a targeted radiation oncology therapy company developing a comprehensive clinical solution for […]
Oramed Announces Top-line Results from Phase 3 Trial of ORMD-0801 for the Treatment of Type 2 Diabetes
Oramed Pharmaceuticals, a clinical-stage pharmaceutical company focused on the development of oral drug delivery platforms, […]
Pheno Therapeutics Announces Worldwide License from UCB to a Novel Program for Neurodegenerative Disease
Pheno Therapeutics, a biotechnology company focused on the discovery and development of small molecule therapeutics […]
Eisai Submits Marketing Autherization Application for Lecanemab as Treatment for Early Alzheimer's Disease in Europe
Eisai and Biogen have announced that Eisai has submitted a marketing authorization application (MAA) for […]
Medivir Partner Infex Therapeutics Receives FDA QIDP Designation
Medivir AB has announced that its partner Infex Therapeutics, a leading anti-infectives specialist, has been […]
AbbVie and Anima Biotech Announce Collaboration for the Discovery and Development of mRNA Biology Modulators
AbbVie and Anima Biotech (Anima) today announced a collaboration to discover and develop mRNA biology modulators […]
Genethon Launches Pivotal Clinical Trial of Gene Therapy for Crigler-Najjar Syndrome, a Rare Liver Disease
Genethon, a unique non-profit gene therapy R&D organization founded by the French Muscular Dystrophy Association […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more